Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

ElevateBio

Biotech & Life Sciences · Waltham, United States · Founded 2018 Unicorn

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$2.5–5B
Latest valuation · 2026
Unlock exact value
Headcount
100–500
Current team size
Unlock exact value

Global footprint

Where ElevateBio has talent and traffic

Web traffic by country
50K monthly visits
across markets
🇺🇸 United States90.6%
🇨🇦 Canada3.6%
🇮🇳 India3%
🇬🇧 United Kingdom2%
Top 4 markets shown

Patent intelligence

$18M patent portfolio · 23 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value
$18M
0.67% of valuation · 6.1× smaller than top peer CRISPR Therapeutics ($107M)
23 active patent families
Where ElevateBio innovates Molecular biologyBioinformaticsSomatostatin receptor 2AgonistImmunology
Above peer median on Legal, Strategic, Market, Economic, Technology

Quality vs same-sector peers

ElevateBio on the five Patsnap quality dimensions

ElevateBio in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where ElevateBio concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across ElevateBio and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See ElevateBio on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.